Tretten Approved for Genetic Clotting Disorder
Rare condition could be life threateningContinue Reading
Rare condition could be life threateningContinue Reading
Expert offers advice on preventing blood clots, dehydration and fatigue over long distancesContinue Reading
But low blood sugar, a side effect of treatment, remains a concern, study authors sayContinue Reading
Study of three patients found ‘excellent’ circulation in transplanted tissueContinue Reading
Researchers say men with sickle cell disease at greater risk for painful conditionContinue Reading
Clots are arising at increasing rate for people using the HeartMate II device, although reasons are unclearContinue Reading
Olysio may cut down on side effects while achieving good responses in patients, experts sayContinue Reading
But serious condition is easily avoided by moving around every few hours, experts sayContinue Reading
One trial found gene tests help with standby med warfarin, another shows promise for newer drugContinue Reading
Atrial fibrillation can lead to dangerous heart complicationsContinue Reading
In early tests, new drug allowed blood to clot again with no apparent side effectsContinue Reading
Study compared short-term survival in severely injured patientsContinue Reading
But first, device must undergo clinical studiesContinue Reading
Risk remained for 28 days after discharge; highest when hospitalization was for 3 or more days, study suggestsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.